The Current Status, Dilemmas, and Breakthrough Strategies of “Co-Treatment of Brain and Heart” for Comorbid Cerebrocardiovascular Diseases
WU Jiarui1, CAO Liming2
1 Shenzhen University Medical School, Shenzhen 518063, China
2 Department of Neurology, Shenzhen Second People’s Hospital (The First Affiliated Hospital of Shenzhen University), Shenzhen 518035, China
WU Jiarui, CAO Liming. The Current Status, Dilemmas, and Breakthrough Strategies of “Co-Treatment of Brain and Heart” for Comorbid Cerebrocardiovascular Diseases[J]. Chinese Journal of Stroke, 2025, 20(11): 1355-1362.
[1]TANG H,XING X R,HAN Y N,et al. A retrospective study of brain-heart syndrome in patients with acute cerebrovascular diseases[J/OL]. Risk Manag Healthc Policy,2024,17:2161-2168[2025-10-21]. https://doi.org/10.2147/RMHP.467205.
[2] 赵继宗. 我国脑心血管共患疾病现状与临床研究[J]. 首都医科大学学报,2022,43(5):671-673.
ZHAO J Z. Current status and clinical research of brain-heart comorbid vascular diseases in China[J]. Journal of Capital Medical University,2022,43(5):671-673.
[3] 赵步长,赵明中.“脑心同治”理论指导心脑血管疾病的防治策略[J]. 中国中西医结合杂志,2013,33(12):1596-1598.
ZHAO B C,ZHAO M Z. Prevention and treatment strategy of cardiovascular and cerebrovascular diseases guided by the theory of“simultaneous treatment of brain and heart”[J]. Chinese Journal of Integrated Traditional and Western Medicine,2013,33(12):1596-1598.
[4] MANEV H. The heart-brain connection begets cardiovascular psychiatry and neurology[J/OL]. Cardiovasc Psychiatry Neurol,2009:546737[2025-10-21]. https://doi.org/10.1155/2009/546737.
[5] SAMUELS M A. The brain-heart connection[J]. Circulation,2007,116(1):77-84.
[6] CHEN Z L,VENKAT P,SEYFRIED D,et al. Brain-heart interaction:cardiac complications after stroke[J]. Circ Res,2017,121(4):451-468.
[7] 韩宁.“心脑同治”学说及益气心脑宁治疗脑梗塞合并冠心病心绞痛的临床研究[D]. 济南:山东中医药大学,2006.
HAN N. The theory of treatment heart and brain with the same methods and the clinical studies of Yiqixinnaoning to prevent and treat cerebralinfaretion combined angina of coronary atherosclerosis heart disease[D]. Jinan:Shandong University of Traditional Chinese Medicine,2006.
[8] MIYAMOTO S,YAMADA K. Paradigm shift in the stroke medical care system[J]. Japanese Journal of Neurosurgery,2021,30(3):194-198.
[9] MORI M,KUWABARA M,NAKATANI Y. The stroke/cerebrovascular and cardiovascular disease control act:current status and future direction[J]. High Brain Function Research,2022,42(2):160-164.
[10] HIXSON E D,NADZAM D M,KATZAN I L,et al. Quality improvement for stroke management at the Cleveland clinic health system[J]. Jt Comm J Qual Patient Saf,2005,31(8):447-454.
[11] ORFANOUDAKI A,CHESLEY E,CADISCH C,et al. Machine learning provides evidence that stroke risk is not linear:the non-linear Framingham stroke risk score[J/OL]. PLoS One,2020,15(5):e0232414[2025-10-21]. https://doi.org/10.1371/journal.pone.0232414.
[12] SPOSATO L A,ASPBERG S,SCHEITZ J F,et al. The World Stroke Organization Brain & Heart Task Force:collaborations between stroke physicians and cardiologists[J]. Eur Heart J,2021,42(36):3594-3596.
[13] 李淑娟,马雅军. 树立“脑心同治”观念助力脑心共病诊断与治疗发展[J]. 中国现代神经疾病杂志,2024,24(2):65-67.
LI S J,MA Y J. Establish the concept of“synchronous treatment for brain and heart”to help the comprehensive diagnosis and treatment of brain and heart comorbidity[J]. Chin J Contemp Neurol Neurosurg,2024,24(2):65-67.
[14] 匡远深. 北京天坛医院推出脑血管病诊治一站式服务[J]. 首都医药,2011,18(1):63.
KUANG Y S. Beijing Tiantan Hospital launches one-stop service for diagnosis and treatment of cerebrovascular diseases[J]. Cap Med,2011,18(1):63.
[15] 夏岩,王晓岩,林发,等. 脑心共患疾病共治与分治模式的卫生经济学比较研究[J]. 中国卒中杂志,2024,19(8):866-872.
XIA Y,WANG X Y,LIN F,et al. A comparative study of health economics of co-management and separate management models for brain-heart comorbidity diseases[J]. Chin J Stroke,2024,19(8):866-872.
[16] 冯瑶,周琪琳,张贵涛,等. 心血管病住院患者院内卒中人群分析的横断面研究[J]. 中华心律失常学杂志,2024,28(4):322-326.
FENG Y,ZHOU Q L,ZHANG G T,et al. Analysis of the in-hospital stroke population among cardiovascular inpatients:a cross-sectional study[J]. Chin J Cardiac Arrhyth,2024,28(4):322-326.
[17] 乌兰察夫. 心脑血管病临床治疗新风向——我国八省市区成立中西医结合学会脑心同治专业委员会[J]. 中国食品药品监管,2013(6):68-69.
WULANCHAFU. New trend in clinical treatment of cardiovascular and cerebrovascular diseases—establishment of Professional Committee of Simultaneous Treatment of Brain and Heart of Integrative Medicine Association in 8 provinces and municipalities of China[J]. China Food & Drug Administration Magazine,2013(6):68-69.
[18] 韦红泉,陈义敏,廖旭兴,等. 基层医院脑心同治的再认识与实践[J]. 现代诊断与治疗,2022,33(22):3344-3347,3476.
WEI H Q,CHEN Y M,LIAO X X,et al. Re-understanding and practice of brain and heart simultaneous treatment in primary hospitals[J]. Mod Diagn Treat,2022,33(22):3344-3347,3476.
[19] 赵艳,朱立峰. 瑞金医院多学科联合门诊(MDT)平台建设探索[J]. 中国数字医学,2018,13(12):68-71.
ZHAO Y,ZHU L F. The exploration of the construction of multidisciplinary outpatient service(MDT)platform of Ruijin Hospital[J]. China Digital Medicine,2018,13(12):68-71.
[20] 范艳梅,陈扬,王丽娟. 门诊MDT诊疗体系的建立[J]. 中国卫生产业,2019,16(35):93-95.
FAN Y M,CHEN Y,WANG L J. Establishment of outpatient MDT diagnosis and treatment system[J]. China Health Industry,2019,16(35):93-95.
[21] “脑心同源、共同防治”,北京地坛医院心脑同治联合门诊3月7日开诊[EB/OL].(2024-03-07)[2025-10-21]. https://health.gmw.cn/2024-03/07/content_37190638. htm.
[22] 徐彭杰,张羽,徐朝霞,等. MDT模式在急性脑卒中患者诊疗中的应用[J]. 成都医学院学报,2018,13(5):606-608.
XU P J,ZHANG Y,XU Z X,et al. Application of the MDT mode in the diagnosis and treatment of acute stroke[J]. Journal of Chengdu Medical College,2018,13(5):606-608.
[23] 夏岩,姜悦. 脑心共患疾病防治体系建设思路和构想[J]. 中华医学杂志,2019,99(39):3043-3046.
XIA Y,JIANG Y. Thoughts and ideas on the establishment for simultaneous prevention and treatment of brain and heart diseases[J]. Natl Med J China,2019,99(39):3043-3046.
[24] 苏维,黄乐松,刘智策,等. 多学科协作工作模式的实施与效果[J]. 护理管理杂志,2013,13(8):607-608.
SU W,HUANG L S,LIU Z C,et al. Application and effects of multi-disciplinary collaborative working mode[J]. Journal of Nursing Administration,2013,13(8):607-608.
[25] Antithrombotic Trialists’Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients[J]. BMJ,2002,324(7329):71-86.
[26] CHARIDIMOU A,SHOAMANESH A,AL-SHAHI SALMAN R,et al. Cerebral amyloid angiopathy,cerebral microbleeds and implications for anticoagulation decisions:the need for a balanced approach[J]. Int J Stroke,2018,13(2):117-120.
[27] NISSEN S E,TUZCU E M,SCHOENHAGEN P,et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis:a randomized controlled trial[J]. JAMA,2004,291(9):1071-1080.
[28] SILVERMAN M G,FERENCE B A,IM K,et al. Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions:a systematic review and meta-analysis[J]. JAMA,2016,316(12):1289-1297.
[29] GUO Q H,LIU C H,WANG J G. Blood pressure goals in acute stroke[J]. Am J Hypertens,2022,35(6):483-499.
[30] MOGENSEN C E,NELDAM S,TIKKANEN I,et al. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension,microalbuminuria,and non-insulin dependent diabetes:the candesartan and lisinopril microalbuminuria(CALM)study[J]. BMJ,2000,321(7274):1440-1444.
[31] 牟建军. 重视生活方式干预,提高高血压管理水平[J]. 中华高血压杂志,2014,22(4):323-325.
MU J J. Attach importance to lifestyle intervention and improve the management level of hypertension[J]. Chin J Hypertens,2014,22(4):323-325.
[32] 王小庆,孙艳,陈丽星,等. 戒烟对冠心病患者血脂、血液流变学及颈动脉内膜中层厚度的影响[J]. 广东医学,2009,30(11):1644-1646.
WANG X Q,SUN Y,CHEN L X,et al. Effects of smoking cessation on blood lipids,hemorheology and thickness of carotid artery intima media in patients with coronary heart disease[J]. Guangdong Medical Journal,2009,30(11):1644-1646.
[33] NGUYEN H,MANOLOVA G,DASKALOPOULOU C,et al. Prevalence of multimorbidity in community settings:a systematic review and meta-analysis of observational studies[J/OL]. J Comorb,2019,9:2235042X19870934[2025-10-21]. https://doi.org/10.1177/2235042X19870934.
[34] CARSON R C,JUSZCZAK M,DAVENPORT A,et al. Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease?[J]. Clin J Am Soc Nephrol,2009,4(10):1611-1619.
[35] 李婵姣,何安宁,黄仙红,等. 国内外多重慢病健康服务整合研究进展[J]. 中国全科医学,2024,27(2):184-191.
LI C J,HE A N,HUANG X H,et al. Research progress of international and domestic integrated health care of multimorbidity[J]. Chinese General Practice,2024,27(2):184-191.
[36] 赵继宗,郭彩霞. 破楚汉界,立新学科——谈谈“脑心同治”[J]. 中华医学杂志,2019,99(39):3041-3042.
ZHAO J Z,GUO C X. Break the boundaries,establish new discipline:comprehensive treatment of cerebro-cardiac disease[J]. Natl Med J China,2019,99(39):3041-3042.
[37] ONDER G,CESARI M,MAGGIO M,et al. Defining a care pathway for patients with multimorbidity or frailty[J/OL]. Eur J Intern Med,2017,38:1-2[2025-10-21]. https://doi.org/10.1016/j.ejim.2017.01.013.
[38] TAKASE B,IKEDA T,SHIMIZU W,et al. JCS/JHRS 2022 guideline on diagnosis and risk assessment of arrhythmia[J]. J Arrhythm,2024,40(4):655-752.
[39] OVEISGHARAN S,GHAFFARPASAND F,SÖRÖS P,et al. Brain,heart,and sudden death[J]. Curr J Neurol,2022,21(1):40-51.
[40] The RAF and RAF NOAC-Investigators. Statin therapy in ischemic stroke patients with atrial fibrillation:efficacy and safety outcomes[J]. Eur Stroke J,2025,10(3):775-783.
[41] AN S J,KIM T J,YOON B W. Epidemiology,risk factors,and clinical features of intracerebral hemorrhage:an update[J]. J Stroke,2017,19(1):3-10.
[42] KOZBERG M G,PEROSA V,GUROL M E,et al. A practical approach to the management of cerebral amyloid angiopathy[J]. Int J Stroke,2021,16(4):356-369.
[43] 程忻. 急性缺血性卒中的血压谜团:颈内动脉重度狭窄患者急性期降压是否安全、有获益?[J]. 中国卒中杂志,2019,14(5):492-494.
CHENG X. The blood pressure conundrum in acute ischemic stroke:is it safe and beneficial to lower blood pressure in patients with severe carotid stenosis?[J]. Chin J Stroke,2019,14(5):492-494.
[44] D’AGOSTINO R B,Sr,VASAN R S,PENCINA M J,et al. General cardiovascular risk profile for use in primary care:the Framingham heart study[J]. Circulation,2008,117(6):743-753.
[45] TABATA N,YAMAMOTO E,HOKIMOTO S,et al. Prognostic value of the CHADS2 score for adverse cardiovascular events in coronary artery disease patients without atrial fibrillation—a multi-center observational cohort study[J/OL]. J Am Heart Assoc,2017,6(8):e006355[2025-10-21]. https://doi.org/10.1161/JAHA.117.006355.
[46] BIVARD A,CHURILOV L,PARSONS M. Artificial intelligence for decision support in acute stroke—current roles and potential[J]. Nat Rev Neurol,2020,16(10):575-585.
[47] 刘利强,李光耀,吉训明. 数智赋能心脑血管病危险因素监测与防治:现状和展望[J]. 中国卒中杂志,2025,20(1):40-47.
LIU L Q,LI G Y,JI X M. Digital intelligence empowering the monitoring and prevention of cardio-cerebrovascular disease risk factors:current status and prospect[J]. Chin J Stroke,2025,20(1):40-47.
[48] 艾婷芳,李剑虹. 我国“互联网+”慢性病管理的应用进展及思考[J]. 中国慢性病预防与控制,2024,32(2):142-146.
AI T F,LI J H. Application progress and thinking of“Internet +”chronic disease management in China[J]. Chin J Prev Contr Chron Dis,2024,32(2):142-146.
[49] KARASHIMA S,KAWAKAMI M,NAMBO H,et al. A hyperaldosteronism subtypes predictive model using ensemble learning[J/OL]. Sci Rep,2023,13(1):3043[2025-10-21]. https://doi.org/10.1038/s41598-023-29653-2.
[50] SAEED A,LOPEZ O,COHEN A,et al. Cardiovascular disease and Alzheimer’s disease:the heart-brain axis[J/OL]. J Am Heart Assoc,2023,12(21):e030780[2025-10-21]. https://doi.org/10.1161/JAHA.123.030780.
[51]FAN X H,CAO J Y,LI M X,et al. Stroke related brain-heart crosstalk:pathophysiology,clinical implications,and underlying mechanisms[J/OL]. Adv Sci(Weinh),2024,11(14):e2307698[2025-10-21]. https://doi.org/10.1002/advs.202307698.